nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine triphosphate—ABCB11—bile duct—bile duct cancer	0.0421	0.0958	CbGeAlD
Adenosine triphosphate—ABCB11—bile—bile duct cancer	0.0323	0.0736	CbGeAlD
Adenosine triphosphate—ABCC2—bile duct—bile duct cancer	0.0214	0.0487	CbGeAlD
Adenosine triphosphate—ABCC2—bile—bile duct cancer	0.0164	0.0374	CbGeAlD
Adenosine triphosphate—NAE1—gall bladder—bile duct cancer	0.0142	0.0323	CbGeAlD
Adenosine triphosphate—APAF1—liver—bile duct cancer	0.00827	0.0188	CbGeAlD
Adenosine triphosphate—HSPA1B—pancreas—bile duct cancer	0.00773	0.0176	CbGeAlD
Adenosine triphosphate—HSPA1A—pancreas—bile duct cancer	0.00773	0.0176	CbGeAlD
Adenosine triphosphate—ARAF—pancreas—bile duct cancer	0.00723	0.0164	CbGeAlD
Adenosine triphosphate—ACVR1B—pancreas—bile duct cancer	0.00702	0.016	CbGeAlD
Adenosine triphosphate—AFG3L2—pancreas—bile duct cancer	0.00669	0.0152	CbGeAlD
Adenosine triphosphate—AMHR2—lymph node—bile duct cancer	0.00656	0.0149	CbGeAlD
Adenosine triphosphate—NAE1—pancreas—bile duct cancer	0.00653	0.0149	CbGeAlD
Adenosine triphosphate—APAF1—lymph node—bile duct cancer	0.00634	0.0144	CbGeAlD
Adenosine triphosphate—ADRBK2—liver—bile duct cancer	0.00581	0.0132	CbGeAlD
Adenosine triphosphate—ACSS1—pancreas—bile duct cancer	0.00539	0.0123	CbGeAlD
Adenosine triphosphate—NT5C2—pancreas—bile duct cancer	0.00528	0.012	CbGeAlD
Adenosine triphosphate—ACVR1—pancreas—bile duct cancer	0.00528	0.012	CbGeAlD
Adenosine triphosphate—ACVRL1—liver—bile duct cancer	0.00527	0.012	CbGeAlD
Adenosine triphosphate—ABCG1—liver—bile duct cancer	0.00527	0.012	CbGeAlD
Adenosine triphosphate—ACSS2—pancreas—bile duct cancer	0.00517	0.0118	CbGeAlD
Adenosine triphosphate—ACSL1—pancreas—bile duct cancer	0.00514	0.0117	CbGeAlD
Adenosine triphosphate—ADCY1—liver—bile duct cancer	0.00511	0.0116	CbGeAlD
Adenosine triphosphate—ABCC9—liver—bile duct cancer	0.00501	0.0114	CbGeAlD
Adenosine triphosphate—HSPA1B—liver—bile duct cancer	0.00492	0.0112	CbGeAlD
Adenosine triphosphate—HSPA1A—liver—bile duct cancer	0.00492	0.0112	CbGeAlD
Adenosine triphosphate—PRKAA1—pancreas—bile duct cancer	0.00486	0.0111	CbGeAlD
Adenosine triphosphate—ARAF—liver—bile duct cancer	0.0046	0.0105	CbGeAlD
Adenosine triphosphate—ACVR1B—liver—bile duct cancer	0.00446	0.0102	CbGeAlD
Adenosine triphosphate—ADRBK2—lymph node—bile duct cancer	0.00445	0.0101	CbGeAlD
Adenosine triphosphate—ASNS—pancreas—bile duct cancer	0.00444	0.0101	CbGeAlD
Adenosine triphosphate—AKT1—pancreas—bile duct cancer	0.00444	0.0101	CbGeAlD
Adenosine triphosphate—ASNA1—liver—bile duct cancer	0.00431	0.00982	CbGeAlD
Adenosine triphosphate—AFG3L2—liver—bile duct cancer	0.00426	0.00969	CbGeAlD
Adenosine triphosphate—NAE1—liver—bile duct cancer	0.00415	0.00946	CbGeAlD
Adenosine triphosphate—ABCG1—lymph node—bile duct cancer	0.00404	0.00919	CbGeAlD
Adenosine triphosphate—ACVRL1—lymph node—bile duct cancer	0.00404	0.00919	CbGeAlD
Adenosine triphosphate—ADCY1—lymph node—bile duct cancer	0.00392	0.00891	CbGeAlD
Adenosine triphosphate—SLC25A4—liver—bile duct cancer	0.00387	0.00881	CbGeAlD
Adenosine triphosphate—ASS1—pancreas—bile duct cancer	0.00387	0.00881	CbGeAlD
Adenosine triphosphate—ABCC9—lymph node—bile duct cancer	0.00384	0.00874	CbGeAlD
Adenosine triphosphate—TNK2—liver—bile duct cancer	0.0038	0.00864	CbGeAlD
Adenosine triphosphate—HSPA1B—lymph node—bile duct cancer	0.00377	0.00858	CbGeAlD
Adenosine triphosphate—HSPA1A—lymph node—bile duct cancer	0.00377	0.00858	CbGeAlD
Adenosine triphosphate—ARAF—lymph node—bile duct cancer	0.00353	0.00802	CbGeAlD
Adenosine triphosphate—ACSS1—liver—bile duct cancer	0.00343	0.00781	CbGeAlD
Adenosine triphosphate—ACVR1B—lymph node—bile duct cancer	0.00342	0.00779	CbGeAlD
Adenosine triphosphate—ABCA1—liver—bile duct cancer	0.00339	0.00773	CbGeAlD
Adenosine triphosphate—ADK—pancreas—bile duct cancer	0.00338	0.00769	CbGeAlD
Adenosine triphosphate—NT5C2—liver—bile duct cancer	0.00336	0.00765	CbGeAlD
Adenosine triphosphate—ACVR1—liver—bile duct cancer	0.00336	0.00765	CbGeAlD
Adenosine triphosphate—ASNA1—lymph node—bile duct cancer	0.00331	0.00753	CbGeAlD
Adenosine triphosphate—ACSS2—liver—bile duct cancer	0.00329	0.00749	CbGeAlD
Adenosine triphosphate—ACSL1—liver—bile duct cancer	0.00327	0.00744	CbGeAlD
Adenosine triphosphate—AFG3L2—lymph node—bile duct cancer	0.00326	0.00743	CbGeAlD
Adenosine triphosphate—ABL2—liver—bile duct cancer	0.00321	0.0073	CbGeAlD
Adenosine triphosphate—NAE1—lymph node—bile duct cancer	0.00319	0.00725	CbGeAlD
Adenosine triphosphate—ABCC8—pancreas—bile duct cancer	0.00313	0.00713	CbGeAlD
Adenosine triphosphate—PRKAA1—liver—bile duct cancer	0.00309	0.00704	CbGeAlD
Adenosine triphosphate—ALK—lymph node—bile duct cancer	0.00303	0.00689	CbGeAlD
Adenosine triphosphate—SLC25A4—lymph node—bile duct cancer	0.00297	0.00675	CbGeAlD
Adenosine triphosphate—TNK2—lymph node—bile duct cancer	0.00291	0.00662	CbGeAlD
Adenosine triphosphate—AKT1—liver—bile duct cancer	0.00282	0.00643	CbGeAlD
Adenosine triphosphate—ASNS—liver—bile duct cancer	0.00282	0.00643	CbGeAlD
Adenosine triphosphate—ADRBK1—lymph node—bile duct cancer	0.00263	0.00599	CbGeAlD
Adenosine triphosphate—ACSS1—lymph node—bile duct cancer	0.00263	0.00599	CbGeAlD
Adenosine triphosphate—ABCB11—liver—bile duct cancer	0.00263	0.00599	CbGeAlD
Adenosine triphosphate—ABCA1—lymph node—bile duct cancer	0.0026	0.00593	CbGeAlD
Adenosine triphosphate—NT5C2—lymph node—bile duct cancer	0.00258	0.00586	CbGeAlD
Adenosine triphosphate—ACVR1—lymph node—bile duct cancer	0.00258	0.00586	CbGeAlD
Adenosine triphosphate—ACSS2—lymph node—bile duct cancer	0.00252	0.00574	CbGeAlD
Adenosine triphosphate—ACSL1—lymph node—bile duct cancer	0.00251	0.00571	CbGeAlD
Adenosine triphosphate—ASS1—liver—bile duct cancer	0.00246	0.0056	CbGeAlD
Adenosine triphosphate—ABL2—lymph node—bile duct cancer	0.00246	0.0056	CbGeAlD
Adenosine triphosphate—ABL1—pancreas—bile duct cancer	0.00243	0.00553	CbGeAlD
Adenosine triphosphate—PRKAA1—lymph node—bile duct cancer	0.00237	0.0054	CbGeAlD
Adenosine triphosphate—ASNS—lymph node—bile duct cancer	0.00216	0.00493	CbGeAlD
Adenosine triphosphate—AKT1—lymph node—bile duct cancer	0.00216	0.00493	CbGeAlD
Adenosine triphosphate—ADK—liver—bile duct cancer	0.00215	0.00489	CbGeAlD
Adenosine triphosphate—ASS1—lymph node—bile duct cancer	0.00189	0.0043	CbGeAlD
Adenosine triphosphate—ADK—lymph node—bile duct cancer	0.00165	0.00375	CbGeAlD
Adenosine triphosphate—ABL1—liver—bile duct cancer	0.00155	0.00352	CbGeAlD
Adenosine triphosphate—ABCC2—liver—bile duct cancer	0.00134	0.00304	CbGeAlD
Adenosine triphosphate—ABL1—lymph node—bile duct cancer	0.00119	0.0027	CbGeAlD
Adenosine triphosphate—ABCC2—lymph node—bile duct cancer	0.00103	0.00233	CbGeAlD
Adenosine triphosphate—ABCB1—pancreas—bile duct cancer	0.000756	0.00172	CbGeAlD
Adenosine triphosphate—ABCB1—liver—bile duct cancer	0.000481	0.00109	CbGeAlD
Adenosine triphosphate—ABCB1—lymph node—bile duct cancer	0.000369	0.00084	CbGeAlD
Adenosine triphosphate—AKT1—DAP12 interactions—IL6—bile duct cancer	0.000103	0.000183	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by EGFR—IL6—bile duct cancer	0.000102	0.000182	CbGpPWpGaD
Adenosine triphosphate—AKT1—Focal Adhesion—HRAS—bile duct cancer	0.000102	0.000181	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by EGFR in Cancer—IL6—bile duct cancer	0.000101	0.00018	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by PDGF—IL6—bile duct cancer	0.000101	0.000179	CbGpPWpGaD
Adenosine triphosphate—ABL1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.0001	0.000179	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by NGF—NRAS—bile duct cancer	0.0001	0.000178	CbGpPWpGaD
Adenosine triphosphate—ADK—Metabolism—PTGS2—bile duct cancer	9.95e-05	0.000178	CbGpPWpGaD
Adenosine triphosphate—AKT1—B Cell Activation—HRAS—bile duct cancer	9.95e-05	0.000177	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—GNAS—bile duct cancer	9.74e-05	0.000174	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—MMP2—bile duct cancer	9.7e-05	0.000173	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—MMP9—bile duct cancer	9.68e-05	0.000173	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—TGFB1—bile duct cancer	9.64e-05	0.000172	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Metabolism—PTGS2—bile duct cancer	9.64e-05	0.000172	CbGpPWpGaD
Adenosine triphosphate—ACSL1—Metabolism—PTGS2—bile duct cancer	9.64e-05	0.000172	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—GNAS—bile duct cancer	9.59e-05	0.000171	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—NRAS—bile duct cancer	9.57e-05	0.000171	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TGFBR2—bile duct cancer	9.55e-05	0.00017	CbGpPWpGaD
Adenosine triphosphate—AKT1—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	9.52e-05	0.00017	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—EGFR—bile duct cancer	9.45e-05	0.000169	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—NRAS—bile duct cancer	9.42e-05	0.000168	CbGpPWpGaD
Adenosine triphosphate—ASNS—Metabolism—PTGS2—bile duct cancer	9.36e-05	0.000167	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—GNAS—bile duct cancer	9.22e-05	0.000164	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—MMP2—bile duct cancer	9.19e-05	0.000164	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by NGF—EGFR—bile duct cancer	9.12e-05	0.000163	CbGpPWpGaD
Adenosine triphosphate—AKT1—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	9.11e-05	0.000162	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—SLC5A5—bile duct cancer	9.06e-05	0.000162	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—MMP9—bile duct cancer	9.06e-05	0.000162	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—SMAD4—bile duct cancer	9.04e-05	0.000161	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—NRAS—bile duct cancer	9.03e-05	0.000161	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—NRAS—bile duct cancer	8.96e-05	0.00016	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—KRAS—bile duct cancer	8.93e-05	0.000159	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—GNAS—bile duct cancer	8.9e-05	0.000159	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—TGFB1—bile duct cancer	8.9e-05	0.000159	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—NOS2—bile duct cancer	8.86e-05	0.000158	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TGFBR2—bile duct cancer	8.8e-05	0.000157	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—EGFR—bile duct cancer	8.72e-05	0.000156	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—GNAS—bile duct cancer	8.71e-05	0.000155	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by NGF—KRAS—bile duct cancer	8.61e-05	0.000154	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—NRAS—bile duct cancer	8.59e-05	0.000153	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—EGFR—bile duct cancer	8.58e-05	0.000153	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—ERBB2—bile duct cancer	8.5e-05	0.000152	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—GNAS—bile duct cancer	8.49e-05	0.000151	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—NOS2—bile duct cancer	8.49e-05	0.000151	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	8.49e-05	0.000151	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TGFBR2—bile duct cancer	8.44e-05	0.000151	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—SMAD4—bile duct cancer	8.33e-05	0.000149	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—TGFB1—bile duct cancer	8.32e-05	0.000148	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—KRAS—bile duct cancer	8.24e-05	0.000147	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—EGFR—bile duct cancer	8.23e-05	0.000147	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—EGFR—bile duct cancer	8.16e-05	0.000146	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—GNAS—bile duct cancer	8.14e-05	0.000145	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—KRAS—bile duct cancer	8.11e-05	0.000145	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—ERBB2—bile duct cancer	8.05e-05	0.000144	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—NRAS—bile duct cancer	8.03e-05	0.000143	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—SMAD4—bile duct cancer	7.99e-05	0.000142	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—SLC5A5—bile duct cancer	7.92e-05	0.000141	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—EGFR—bile duct cancer	7.82e-05	0.00014	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—KRAS—bile duct cancer	7.77e-05	0.000139	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—SMAD4—bile duct cancer	7.76e-05	0.000138	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Metabolism—PTGS2—bile duct cancer	7.74e-05	0.000138	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—KRAS—bile duct cancer	7.71e-05	0.000137	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—TGFBR2—bile duct cancer	7.62e-05	0.000136	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—HRAS—bile duct cancer	7.59e-05	0.000135	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HGF—bile duct cancer	7.58e-05	0.000135	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—ERBB2—bile duct cancer	7.5e-05	0.000134	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—TGFB1—bile duct cancer	7.46e-05	0.000133	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	7.43e-05	0.000133	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—KRAS—bile duct cancer	7.39e-05	0.000132	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by NGF—HRAS—bile duct cancer	7.32e-05	0.000131	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—EGFR—bile duct cancer	7.32e-05	0.000131	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—MMP9—bile duct cancer	7.29e-05	0.00013	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	7.26e-05	0.00013	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—IL6—bile duct cancer	7.26e-05	0.00013	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—ERBB2—bile duct cancer	7.21e-05	0.000129	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—SMAD4—bile duct cancer	7.21e-05	0.000129	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—ERBB2—bile duct cancer	7.2e-05	0.000128	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HGF—bile duct cancer	7.19e-05	0.000128	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—ERBB2—bile duct cancer	7.11e-05	0.000127	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—GNAS—bile duct cancer	7.04e-05	0.000126	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by NGF—IL6—bile duct cancer	7.01e-05	0.000125	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—HRAS—bile duct cancer	7e-05	0.000125	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—ERBB2—bile duct cancer	6.92e-05	0.000123	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—KRAS—bile duct cancer	6.91e-05	0.000123	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	6.91e-05	0.000123	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—MMP9—bile duct cancer	6.91e-05	0.000123	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—HRAS—bile duct cancer	6.89e-05	0.000123	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—IL6—bile duct cancer	6.7e-05	0.00012	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—ERBB2—bile duct cancer	6.66e-05	0.000119	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—HRAS—bile duct cancer	6.61e-05	0.000118	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—IL6—bile duct cancer	6.6e-05	0.000118	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—HRAS—bile duct cancer	6.55e-05	0.000117	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—PTGS2—bile duct cancer	6.51e-05	0.000116	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—NRAS—bile duct cancer	6.46e-05	0.000115	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—ERBB2—bile duct cancer	6.38e-05	0.000114	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—NRAS—bile duct cancer	6.34e-05	0.000113	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—IL6—bile duct cancer	6.32e-05	0.000113	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—HRAS—bile duct cancer	6.28e-05	0.000112	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—IL6—bile duct cancer	6.27e-05	0.000112	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—PTGS2—bile duct cancer	6.24e-05	0.000111	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—GNAS—bile duct cancer	6.15e-05	0.00011	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—TP53—bile duct cancer	6.15e-05	0.00011	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—NRAS—bile duct cancer	6.13e-05	0.000109	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—IL6—bile duct cancer	6.01e-05	0.000107	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—NRAS—bile duct cancer	6.01e-05	0.000107	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—NRAS—bile duct cancer	6.01e-05	0.000107	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—TGFB1—bile duct cancer	6.01e-05	0.000107	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—TGFB1—bile duct cancer	5.89e-05	0.000105	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—EGFR—bile duct cancer	5.89e-05	0.000105	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—HRAS—bile duct cancer	5.88e-05	0.000105	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—NRAS—bile duct cancer	5.76e-05	0.000103	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—NRAS—bile duct cancer	5.71e-05	0.000102	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—IDH2—bile duct cancer	5.71e-05	0.000102	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—TGFB1—bile duct cancer	5.69e-05	0.000102	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—IL6—bile duct cancer	5.62e-05	0.0001	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—TGFB1—bile duct cancer	5.59e-05	9.96e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—EGFR—bile duct cancer	5.58e-05	9.96e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—KRAS—bile duct cancer	5.56e-05	9.92e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—NRAS—bile duct cancer	5.49e-05	9.79e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—NRAS—bile duct cancer	5.48e-05	9.78e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—EGFR—bile duct cancer	5.47e-05	9.76e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—KRAS—bile duct cancer	5.46e-05	9.73e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—NRAS—bile duct cancer	5.41e-05	9.65e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	5.37e-05	9.58e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—NOS2—bile duct cancer	5.37e-05	9.57e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TGFBR2—bile duct cancer	5.33e-05	9.51e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—KRAS—bile duct cancer	5.27e-05	9.41e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—NRAS—bile duct cancer	5.26e-05	9.38e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	5.25e-05	9.37e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—EGFR—bile duct cancer	5.25e-05	9.36e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—PTGS2—bile duct cancer	5.23e-05	9.32e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—EGFR—bile duct cancer	5.2e-05	9.28e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—KRAS—bile duct cancer	5.17e-05	9.23e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—KRAS—bile duct cancer	5.17e-05	9.22e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	5.15e-05	9.18e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—GNAS—bile duct cancer	5.14e-05	9.17e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—NRAS—bile duct cancer	5.07e-05	9.04e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—ERBB2—bile duct cancer	5.06e-05	9.03e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—SMAD4—bile duct cancer	5.05e-05	9e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—EGFR—bile duct cancer	5e-05	8.92e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—EGFR—bile duct cancer	4.99e-05	8.91e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—KRAS—bile duct cancer	4.96e-05	8.84e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—EGFR—bile duct cancer	4.93e-05	8.79e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—KRAS—bile duct cancer	4.91e-05	8.76e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—IDH1—bile duct cancer	4.91e-05	8.75e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	4.86e-05	8.68e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—NRAS—bile duct cancer	4.86e-05	8.66e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—TP53—bile duct cancer	4.85e-05	8.65e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—EGFR—bile duct cancer	4.79e-05	8.55e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—PTGS2—bile duct cancer	4.78e-05	8.53e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—HRAS—bile duct cancer	4.73e-05	8.43e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—KRAS—bile duct cancer	4.72e-05	8.42e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—KRAS—bile duct cancer	4.72e-05	8.41e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—TGFB1—bile duct cancer	4.71e-05	8.4e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—ERBB2—bile duct cancer	4.66e-05	8.32e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—KRAS—bile duct cancer	4.66e-05	8.31e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—HRAS—bile duct cancer	4.64e-05	8.27e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—EGFR—bile duct cancer	4.62e-05	8.23e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—TP53—bile duct cancer	4.6e-05	8.2e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—KRAS—bile duct cancer	4.53e-05	8.08e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—IL6—bile duct cancer	4.53e-05	8.07e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—TGFB1—bile duct cancer	4.51e-05	8.05e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—HRAS—bile duct cancer	4.48e-05	7.99e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—ERBB2—bile duct cancer	4.47e-05	7.97e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—EGFR—bile duct cancer	4.43e-05	7.89e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—HRAS—bile duct cancer	4.4e-05	7.84e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—HRAS—bile duct cancer	4.39e-05	7.84e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—ERBB2—bile duct cancer	4.37e-05	7.79e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—KRAS—bile duct cancer	4.36e-05	7.78e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MMP9—bile duct cancer	4.34e-05	7.74e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	4.32e-05	7.71e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—IL6—bile duct cancer	4.29e-05	7.65e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—HRAS—bile duct cancer	4.21e-05	7.51e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—IL6—bile duct cancer	4.21e-05	7.5e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—KRAS—bile duct cancer	4.18e-05	7.46e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—HRAS—bile duct cancer	4.18e-05	7.45e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—ERBB2—bile duct cancer	4.14e-05	7.39e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—ERBB2—bile duct cancer	4.03e-05	7.2e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—IL6—bile duct cancer	4.03e-05	7.19e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—HRAS—bile duct cancer	4.01e-05	7.16e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—HRAS—bile duct cancer	4.01e-05	7.15e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MMP9—bile duct cancer	4e-05	7.13e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—IL6—bile duct cancer	4e-05	7.13e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—HRAS—bile duct cancer	3.96e-05	7.06e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PTGS2—bile duct cancer	3.95e-05	7.04e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—NRAS—bile duct cancer	3.85e-05	6.87e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—HRAS—bile duct cancer	3.85e-05	6.86e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—IL6—bile duct cancer	3.84e-05	6.85e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MMP9—bile duct cancer	3.84e-05	6.84e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—IL6—bile duct cancer	3.79e-05	6.76e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PTGS2—bile duct cancer	3.78e-05	6.74e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—HRAS—bile duct cancer	3.71e-05	6.61e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—IL6—bile duct cancer	3.68e-05	6.57e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—NRAS—bile duct cancer	3.64e-05	6.49e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TGFB1—bile duct cancer	3.58e-05	6.38e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—HRAS—bile duct cancer	3.55e-05	6.34e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—NRAS—bile duct cancer	3.55e-05	6.33e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—IL6—bile duct cancer	3.55e-05	6.33e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—EGFR—bile duct cancer	3.51e-05	6.26e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—NRAS—bile duct cancer	3.4e-05	6.07e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—IL6—bile duct cancer	3.4e-05	6.07e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—NRAS—bile duct cancer	3.32e-05	5.93e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—EGFR—bile duct cancer	3.32e-05	5.91e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—KRAS—bile duct cancer	3.31e-05	5.91e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PTGS2—bile duct cancer	3.3e-05	5.89e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TGFB1—bile duct cancer	3.3e-05	5.88e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—SLC5A5—bile duct cancer	3.24e-05	5.77e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—EGFR—bile duct cancer	3.23e-05	5.77e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TGFB1—bile duct cancer	3.16e-05	5.64e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—NRAS—bile duct cancer	3.15e-05	5.62e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—KRAS—bile duct cancer	3.13e-05	5.59e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—EGFR—bile duct cancer	3.1e-05	5.53e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—NRAS—bile duct cancer	3.07e-05	5.47e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—KRAS—bile duct cancer	3.05e-05	5.45e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—EGFR—bile duct cancer	3.03e-05	5.4e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TP53—bile duct cancer	2.95e-05	5.25e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—KRAS—bile duct cancer	2.93e-05	5.22e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—EGFR—bile duct cancer	2.87e-05	5.12e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—KRAS—bile duct cancer	2.86e-05	5.1e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—TGFB1—bile duct cancer	2.85e-05	5.09e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—ERBB2—bile duct cancer	2.83e-05	5.04e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—HRAS—bile duct cancer	2.82e-05	5.02e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—EGFR—bile duct cancer	2.8e-05	4.99e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TP53—bile duct cancer	2.71e-05	4.84e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—KRAS—bile duct cancer	2.71e-05	4.84e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—IL6—bile duct cancer	2.7e-05	4.81e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—HRAS—bile duct cancer	2.66e-05	4.75e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—KRAS—bile duct cancer	2.64e-05	4.71e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TP53—bile duct cancer	2.6e-05	4.64e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—HRAS—bile duct cancer	2.6e-05	4.63e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—IL6—bile duct cancer	2.55e-05	4.54e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—GNAS—bile duct cancer	2.52e-05	4.49e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—HRAS—bile duct cancer	2.49e-05	4.44e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—IL6—bile duct cancer	2.48e-05	4.43e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HRAS—bile duct cancer	2.43e-05	4.34e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MMP9—bile duct cancer	2.42e-05	4.32e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—IL6—bile duct cancer	2.38e-05	4.25e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL6—bile duct cancer	2.33e-05	4.15e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HRAS—bile duct cancer	2.31e-05	4.11e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—HRAS—bile duct cancer	2.25e-05	4.01e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL6—bile duct cancer	2.21e-05	3.94e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—NRAS—bile duct cancer	2.15e-05	3.83e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—IL6—bile duct cancer	2.15e-05	3.83e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TGFB1—bile duct cancer	2e-05	3.56e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—EGFR—bile duct cancer	1.96e-05	3.49e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—KRAS—bile duct cancer	1.85e-05	3.3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TP53—bile duct cancer	1.64e-05	2.93e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—HRAS—bile duct cancer	1.57e-05	2.8e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IL6—bile duct cancer	1.51e-05	2.68e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PTGS2—bile duct cancer	1.35e-05	2.41e-05	CbGpPWpGaD
